Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $143.76 million. The enterprise value is $145.07 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 27.33 million shares outstanding. The number of shares has increased by 19.90% in one year.
| Current Share Class | 21.33M |
| Shares Outstanding | 27.33M |
| Shares Change (YoY) | +19.90% |
| Shares Change (QoQ) | +8.60% |
| Owned by Insiders (%) | 11.44% |
| Owned by Institutions (%) | 43.96% |
| Float | 14.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 72.55 |
| PS Ratio | 2.32 |
| Forward PS | 1.64 |
| PB Ratio | 4.48 |
| P/TBV Ratio | 33.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.80.
| Current Ratio | 1.79 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.21 |
Financial Efficiency
Return on equity (ROE) is -44.03% and return on invested capital (ROIC) is -27.51%.
| Return on Equity (ROE) | -44.03% |
| Return on Assets (ROA) | -5.84% |
| Return on Invested Capital (ROIC) | -27.51% |
| Return on Capital Employed (ROCE) | -14.30% |
| Weighted Average Cost of Capital (WACC) | 10.22% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$197,086 |
| Employee Count | 58 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.74 |
Taxes
In the past 12 months, Journey Medical has paid $60,000 in taxes.
| Income Tax | 60,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.77% in the last 52 weeks. The beta is 1.04, so Journey Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -12.77% |
| 50-Day Moving Average | 7.15 |
| 200-Day Moving Average | 7.50 |
| Relative Strength Index (RSI) | 37.27 |
| Average Volume (20 Days) | 375,170 |
Short Selling Information
The latest short interest is 3.46 million, so 12.65% of the outstanding shares have been sold short.
| Short Interest | 3.46M |
| Short Previous Month | 2.63M |
| Short % of Shares Out | 12.65% |
| Short % of Float | 23.29% |
| Short Ratio (days to cover) | 25.48 |
Income Statement
In the last 12 months, Journey Medical had revenue of $61.86 million and -$11.43 million in losses. Loss per share was -$0.47.
| Revenue | 61.86M |
| Gross Profit | 40.93M |
| Operating Income | -8.17M |
| Pretax Income | -11.37M |
| Net Income | -11.43M |
| EBITDA | -3.91M |
| EBIT | -8.17M |
| Loss Per Share | -$0.47 |
Full Income StatementBalance Sheet
The company has $24.09 million in cash and $25.40 million in debt, with a net cash position of -$1.31 million or -$0.05 per share.
| Cash & Cash Equivalents | 24.09M |
| Total Debt | 25.40M |
| Net Cash | -1.31M |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 31.85M |
| Book Value Per Share | 1.17 |
| Working Capital | 29.43M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.44M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.26M |
| Net Borrowing | -625,000 |
| Free Cash Flow | -12.44M |
| FCF Per Share | -$0.46 |
Full Cash Flow StatementMargins
Gross margin is 66.17%, with operating and profit margins of -13.21% and -18.48%.
| Gross Margin | 66.17% |
| Operating Margin | -13.21% |
| Pretax Margin | -18.38% |
| Profit Margin | -18.48% |
| EBITDA Margin | -6.33% |
| EBIT Margin | -13.21% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.90% |
| Shareholder Yield | -19.90% |
| Earnings Yield | -7.95% |
| FCF Yield | -8.65% |
Analyst Forecast
The average price target for Journey Medical is $12.67, which is 140.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.67 |
| Price Target Difference | 140.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 0.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.85 |
| Piotroski F-Score | 2 |
